Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
about
Multifunctional DDX3: dual roles in various cancer development and its related signaling pathwaysDDX3, a potential target for cancer treatmentCoupling between the DEAD-box RNA helicases Ded1p and eIF4AIdentification of novel cancer therapeutic targets using a designed and pooled shRNA library screenIdentification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancerAutoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3.DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.Analog sensitive chemical inhibition of the DEAD-box protein DDX3Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development.Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.DHX33 Transcriptionally Controls Genes Involved in the Cell CycleDDX59 promotes DNA replication in lung adenocarcinoma.The prognostic effect of DDX3 upregulation in distant breast cancer metastases.Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer.RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3Wnt signaling as potential therapeutic target in lung cancer.Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.(DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit.RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.The helicase, DDX3X, interacts with poly(A)-binding protein 1 (PABP1) and caprin-1 at the leading edge of migrating fibroblasts and is required for efficient cell spreadingCancer-associated DDX3X mutations drive stress granule assembly and impair global translation.Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Dengue Virus Capsid Interacts with DDX3X-A Potential Mechanism for Suppression of Antiviral Functions in Dengue Infection.Targeting RNA helicases in cancer: The translation trap.Role of DDX3 in the pathogenesis of inflammatory bowel disease.MOLIERE: Automatic Biomedical Hypothesis Generation System.Targeted inactivation of murine Ddx3x: essential roles of Ddx3x in placentation and embryogenesis.Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach.DDX5 RNA Helicases: Emerging Roles in Viral Infection.Patent highlights: December 2015-January 2016.DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4Abnormal expression of YEATS4 associates with poor prognosis and promotes cell proliferation of hepatic carcinoma cell by regulation the TCEA1/DDX3 axis
P2860
Q26749143-43EBA4E2-F081-4A7D-A86A-76EB1DDCBBEAQ26779054-FAB212FC-A2B7-44D8-8B9F-819CD90A5698Q27468894-5B6831D0-7388-45AF-828C-EDCF1A960690Q36287067-116A4056-5D04-4DA3-AB32-8A9D719B6BC7Q36414044-4A402B4D-72DB-4D08-BFD6-1C926FA50715Q36518348-5BEED8F6-F43A-45E9-A973-B41735356F4EQ36595592-DFFB53C0-486C-4E0E-BC32-44EE3C2630ADQ36749699-BE3AE98A-C98A-4F7E-8B23-BBDC6624A2D1Q36904981-FED1FC57-C4D6-42CF-9E32-03EF512EBB90Q36930741-19692D73-057A-4A6A-8687-3524440A4E78Q37227844-B3235340-9650-4C8A-B2E1-3E12E2F3B6E5Q37317515-335A49D3-EA43-40F0-8CF9-A397EF7C7350Q37413655-24248206-8EC0-46F8-AD5D-5FB56B48F874Q37572189-460E5E57-6F60-4415-AFC7-7808D9EC7177Q37617548-CD39E8FE-3DBF-4A6F-8604-FE1BE6365DADQ38718686-7B42ED96-D3C9-4A6A-8BE0-342615409A2EQ38734333-88CA47F9-9D55-4F0A-99F5-5E29E452F10EQ38735754-5D927152-BA14-4CEF-BFCA-C3C84769387CQ38998990-FF6C8CE5-AE61-4100-A609-77FDC90CD7CAQ40100476-D9D09B30-13F2-46FD-BC84-56B7B092504EQ40246228-26359DF1-61C9-452D-A325-5AE5BDE1A832Q40545030-77D93E79-5C62-41DC-8FEA-71679DF165FEQ41534142-F55684DE-8B31-4299-81B3-918337FCFAA4Q41568959-6324E5FA-A6BE-4299-A5BB-E2A2401453B1Q42106717-22CACA01-5240-4CAE-A1DD-1A050C5D624CQ46312467-04BDFC2A-D8AD-4F10-AAE0-48F05BCF9E57Q46721978-CC941660-B4EE-43BB-AB2B-A12EAE8FF30EQ47547342-0DA2AAA7-4E35-4AD0-9965-6BCAA7B02A8EQ47719079-5AA2A287-13C6-49C2-BAF2-46F30CC536BEQ49569343-AE5E63D6-4F62-4584-BA53-BC7ECF059233Q50048255-C0E3C6C1-3585-4AA0-AABF-1DD9969488C1Q50512912-15B47901-D8F4-42CE-BB6D-410ECD89E9CFQ52717362-371BA761-8BDD-4E76-97B1-C1EDC12FAF94Q52720017-881B6788-D8CF-4B93-9928-9C8FB600E99FQ54096626-F2663FE5-214E-40B7-A654-C110E2A0DFE4Q57753756-DD7B103B-8476-44B5-914D-B21632EB7574Q58790046-83FCFBF1-D39D-427D-94FD-AEF745502A39
P2860
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@ast
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@en
type
label
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@ast
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@en
prefLabel
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@ast
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@en
P2093
P2860
P50
P356
P1476
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
@en
P2093
Anne Levine
Ashley Irving
Atul Kondaskar
Dorian Korz
Elsken van der Wall
Evan A Bordt
Kathleen Gabrielson
Khaled Aziz
Leslie Cope
P2860
P304
P356
10.15252/EMMM.201404368
P577
2015-03-27T00:00:00Z